| Andrew J Lawrence, MD | |
|
1723 Broadway St Ste 315, Cape Girardeau, MO 63701-4556 | |
| (573) 519-4960 | |
| (573) 519-4655 |
| Full Name | Andrew J Lawrence |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 1723 Broadway St Ste 315, Cape Girardeau, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306133129 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeasthealth | Cape girardeau, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Health Facilities Rehab Services Inc | 3476679226 | 101 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
| Southeast Missouri Hospital Physicians Llc | 9133024334 | 186 |
News Archive
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
Sangamo BioSciences, Inc., a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire plc, have agreed to revise their January 2012 collaboration and license agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington's disease.
The entire structure of health-care delivery for effective antibiotics – from research and development, to distribution and rational use – needs to be re-engineered to address the looming global threat of antibiotic resistance, say the authors of a new report, published today [Sunday 17 November] in The Lancet Infectious Diseases, ahead of European Antibiotic Awareness Day, and the US Centers for Disease Control and Prevention (CDC) ‘Get Smart About Antibiotics Week' on Monday 18 November.
According to a new study in the American Journal of Preventive Medicine, almost 75 percent of US adults do not comply with public health guidelines recommending two or more muscle-strengthening exercise sessions a week, with nearly 60 percent of the population doing no MSE at all.
› Verified 5 days ago
| Entity Name | Southeast Missouri Hospital Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558311522 PECOS PAC ID: 9133024334 Enrollment ID: O20031201000775 |
News Archive
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
Sangamo BioSciences, Inc., a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire plc, have agreed to revise their January 2012 collaboration and license agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington's disease.
The entire structure of health-care delivery for effective antibiotics – from research and development, to distribution and rational use – needs to be re-engineered to address the looming global threat of antibiotic resistance, say the authors of a new report, published today [Sunday 17 November] in The Lancet Infectious Diseases, ahead of European Antibiotic Awareness Day, and the US Centers for Disease Control and Prevention (CDC) ‘Get Smart About Antibiotics Week' on Monday 18 November.
According to a new study in the American Journal of Preventive Medicine, almost 75 percent of US adults do not comply with public health guidelines recommending two or more muscle-strengthening exercise sessions a week, with nearly 60 percent of the population doing no MSE at all.
› Verified 5 days ago
| Entity Name | Mercy Clinic East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851335228 PECOS PAC ID: 7214827922 Enrollment ID: O20070521000006 |
News Archive
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
Sangamo BioSciences, Inc., a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire plc, have agreed to revise their January 2012 collaboration and license agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington's disease.
The entire structure of health-care delivery for effective antibiotics – from research and development, to distribution and rational use – needs to be re-engineered to address the looming global threat of antibiotic resistance, say the authors of a new report, published today [Sunday 17 November] in The Lancet Infectious Diseases, ahead of European Antibiotic Awareness Day, and the US Centers for Disease Control and Prevention (CDC) ‘Get Smart About Antibiotics Week' on Monday 18 November.
According to a new study in the American Journal of Preventive Medicine, almost 75 percent of US adults do not comply with public health guidelines recommending two or more muscle-strengthening exercise sessions a week, with nearly 60 percent of the population doing no MSE at all.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew J Lawrence, MD 1723 Broadway St Ste 315, Cape Girardeau, MO 63701-4556 Ph: (573) 519-4960 | Andrew J Lawrence, MD 1723 Broadway St Ste 315, Cape Girardeau, MO 63701-4556 Ph: (573) 519-4960 |
News Archive
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
Sangamo BioSciences, Inc., a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire plc, have agreed to revise their January 2012 collaboration and license agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington's disease.
The entire structure of health-care delivery for effective antibiotics – from research and development, to distribution and rational use – needs to be re-engineered to address the looming global threat of antibiotic resistance, say the authors of a new report, published today [Sunday 17 November] in The Lancet Infectious Diseases, ahead of European Antibiotic Awareness Day, and the US Centers for Disease Control and Prevention (CDC) ‘Get Smart About Antibiotics Week' on Monday 18 November.
According to a new study in the American Journal of Preventive Medicine, almost 75 percent of US adults do not comply with public health guidelines recommending two or more muscle-strengthening exercise sessions a week, with nearly 60 percent of the population doing no MSE at all.
› Verified 5 days ago
Lori A Moyers, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3129 Blattner Dr, Cape Girardeau, MO 63703 Phone: 573-335-0166 Fax: 573-335-7942 | |
Dr. Roderic Clayton Crist, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3095 Lexington Ave, Suite 200, Cape Girardeau, MO 63701 Phone: 573-339-0004 | |
John Van Earnhart, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 150 S Mount Auburn Rd, Suite 418, Cape Girardeau, MO 63703 Phone: 573-332-6000 | |
Kenneth Dean Phillips Jr., MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 8 Doctors Park, Cape Girardeau, MO 63703 Phone: 573-651-1333 Fax: 573-651-1324 | |
John V. Mackel, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 310 S Silver Springs Rd, Cape Girardeau, MO 63703 Phone: 573-334-9637 Fax: 573-335-0147 | |
Dr. Jehan Pascal Murugaser, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 817 S Mount Auburn Rd, Cape Girardeau, MO 63703 Phone: 573-519-4500 Fax: 573-519-4530 | |
Dr. James E Palen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3129 Blattner Dr, Cape Girardeau, MO 63703 Phone: 573-335-0166 Fax: 573-335-7942 |